Rchr
J-GLOBAL ID:201701016935864202
Update date: Feb. 01, 2024
Fumihito Ueda
ウエダ フミヒト | Fumihito Ueda
Affiliation and department:
Job title:
Research Associate/Assistant Professor/Instructor
Research field (2):
Cell biology
, Molecular biology
Research theme for competitive and other funds (3):
- 2022 - 2025 ALCL病態に関わる異常DNAメチル化の解明
- 2020 - 2022 Mechanisms of initiation and progression of thymic epithelial tumor
- 2018 - 2020 Hippo経路破綻による舌がん発症マウスモデルの樹立
Papers (14):
-
Hirofumi Omori, Miki Nishio, Muneyuki Masuda, Yosuke Miyachi, Fumihito Ueda, Takafumi Nakano, Kuniaki Sato, Koshi Mimori, Kenichi Taguchi, Hiroki Hikasa, et al. YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma. Science advances. 2020. 6. 12. eaay3324
-
Funakoshi-Tago, M, Tsuruya, R, Ueda, F, Ishihara, A, Kasahara, T, Tamura, H, Tago, K. Tyrosine-phosphorylated SOCS3 negatively regulates cellular transformation mediated by the myeloproliferative neoplasm-associated JAK2 V617F mutant. Cytokine. 2019. 123. 154753
-
Miki Nishio, Yousuke Miyachi, Junji Otani, Shoji Tane, Hirofumi Omori, Fumihito Ueda, Hideru Togashi, Takehiko Sasaki, Tak Wah Mak, Kazuwa Nakao, et al. Hippo pathway controls cell adhesion and context-dependent cell competition to influence skin engraftment efficiency. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2019. 33. 4. 5548-5560
-
Funakoshi-Tago, M, Moriwaki, T, Ueda, F, Tamura, H, Kasahara, T, Tago, K. Phosphorylated CIS suppresses the Epo or JAK2 V617F mutant-triggered cell proliferation through binding to EpoR. Cell Signal. 2017. 31. 41-57
-
Fumihito Ueda, Kenji Tago, Hiroomi Tamura, Megumi Funakoshi-Tago. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis. JOURNAL OF BIOLOGICAL CHEMISTRY. 2017. 292. 5. 1826-1846
more...
Lectures and oral presentations (1):
-
Hippoシグナル経路による細胞増殖変化と細胞間コミュニケーション
(新学術領域「幹細胞老化と疾患」「細胞競合」総括班主催「若手の会」 2018)
Education (1):
- - 2017 慶応義塾大学 大学院薬学研究科博士後期課程修了
Professional career (2):
- 修士(薬学) (慶應義塾大学)
- 博士(薬学) (慶應義塾大学)
Work history (2):
- 2020/04/01 - 現在 Keio University
- 2017/04/01 - 2020/03/31 Kobe University
Return to Previous Page